Clinical Trials Logo

Population clinical trials

View clinical trials related to Population.

Filter by:
  • None
  • Page 1

NCT ID: NCT06093178 Not yet recruiting - Life Style, Healthy Clinical Trials

Assessing the Feasibility of a Coach-led Digital Platform

Connect5
Start date: May 1, 2024
Phase:
Study type: Observational

This research is taking place to find out if a smartphone app plus a health coach can support citizens of Athy, Co. Kildare Ireland to make healthy changes in your lifestyle - small changes for better health. This is the first study of its kind in Ireland; Athy is the first town to take part. Connect5 Athy smartphone app will have a health coach who will advise and support participants make new healthy lifestyle habits linked to sleep, managing stress, increasing physical activity, support healthy eating, cultivate positive local relationships, and help to avoid risky substances like tobacco and alcohol. This is a 6-month observational study that will be conducted between May and October 2024.

NCT ID: NCT01831648 Completed - Population Clinical Trials

Establishment of Reference Values for Insulin-like Growth Factor 1 (IGF1) in the General Population

VARIETE
Start date: May 2010
Phase: N/A
Study type: Interventional

Various assays can be used for IGF-I measurement in French laboratories. Unfortunately, each assay gives a very different result for the same sample. As IGF-I also varies with age, it is necessary to establish a broad population reference values of IGF1 concentration for each of the IGF1 assays used in clinical practice, taking into account individual variation factors such as age, nutritional status and possible treatments. The objective of this study is to establish normative data based on a large random selection from the general population, including representation from all age groups (around 100 subjects for each decade age range). This will be performed for all the available assay kits. Subjects with medical conditions and medications that may affect the outcome will be excluded. Normative data will include the range (2.5 to 97.5 percentiles) in mass units and results will be reported as mass units but also as SD scores in order to be able, in a given patient, to compare its IGF-I concentration along time, even if using different assays.